Introduction
============

Antioxidant activity (AOA) is a very important parameter used to characterize different plant materials. This activity is related with compounds capable of protecting a biological system against the potential harmful effects of oxidative processes. Antioxidants have received increased attention in the last years from nutritionists and medical researchers for their potential activities in the prevention of several degenerative diseases such as cancer and cardiovascular disorder, as well as aging \[[@B1-molecules-13-00749],[@B2-molecules-13-00749],[@B3-molecules-13-00749],[@B4-molecules-13-00749]\]. In recent years, several works have been published on structure-activities analysis on compounds with antioxidant activities. In the works of Rasulev \[[@B5-molecules-13-00749]\] and Amic \[[@B6-molecules-13-00749]\] on flavonoids, it was shown that quantum-chemical descriptors are very important in the description of their activities.

Various biological activities have been attributed to amides and their derivatives, including pharmacological roles, prevention and treatment of tissue damage, involvement in inflammatory sites, the treatment of psoriasis and ulcerative colitis, etc. \[[@B7-molecules-13-00749]\]. The ready access to plant material, the abundance of natural products therein, as well the ease of extraction make amides useful starting materials for the preparation of potentially bioactive compounds \[[@B8-molecules-13-00749]\].

On the other hand, are few reports on antioxidant activity of synthetic compounds \[[@B9-molecules-13-00749],[@B10-molecules-13-00749],[@B11-molecules-13-00749]\]. Consequently the synthesis of new active derivatives with potential applications in this area and prepared by simple chemical procedures should be of increasing interest. In the present study we report the chemical synthesis of some compounds structurally related to diphenylpropionamide derivatives, their biological activity and a computational QSAR analysis.

Results and Discussion
======================

As shown in [Scheme 1](#molecules-13-00749-f004){ref-type="scheme"}, amides **1**-**11** were obtained by direct condensation of 2,2- and 3,3- diphenylpropionic acid and appropriate amines using *n*-propylphosphonic acid anhydride (PPAA) as catalyst \[[@B12-molecules-13-00749]\]. [Table 1](#molecules-13-00749-t001){ref-type="table"} shows the structures of the compounds tested for their antioxidant activity, the latter being expressed both as percent reduction of the absorbance due to the ABTS radical and as T.E.A.C. (Trolox^®^ Equivalent Antioxidant Capacity, µM) values. In this Table the biological activity (expressed as LD~50~ in ppm) of the compounds in the brine shrimp test is also reported.

![Synthesis of compounds **1-11.**](molecules-13-00749-g004){#molecules-13-00749-f004}

The maximum antioxidant activity was exhibited by compounds **3** and **8** (78.19 % and 71.4 %, respectively), having a morpholine ring as substituent R\". Also compounds **4** and **9**, with a methoxybenzylmethyl group as substituent R\", showed a moderate antioxidant activity (41.8 % and 33.93 %, respectively). Among the tested compounds, the samples **3**, **4** and **8**, showing the best antioxidative activity, were also assayed by evaluation of ROS and NO production in the murine macrophage cell line J774.A1 stimulated with LPS. One hour incubation with compounds **3**, **4** or **8** (0.01-1 µM) resulted in a concentration-dependent ROS reduction in J774.A1 ([Figure 1](#molecules-13-00749-f001){ref-type="fig"}). Furthermore, incubation with compounds **3**, **4** or **8** (0.01-1 µM) concentration-dependently reduced nitrite production in J774.A1 at 24 h ([Figure 2](#molecules-13-00749-f002){ref-type="fig"}).

![Effect of compounds **3**, **4** and **8** on ROS production in J774.A1 macrophages.](molecules-13-00749-g001){#molecules-13-00749-f001}

![Effect of compounds **3**, **4** and **8** to LPS-stimulated macrophages J774.A1 on NO release.](molecules-13-00749-g002){#molecules-13-00749-f002}

The brine shrimp lethality bioassay is an efficient, rapid and inexpensive test developed as pre-screening to evaluate biological activities of natural or synthetic compounds. This test is often used as a guide for fractionating extracts from natural sources \[[@B13-molecules-13-00749],[@B14-molecules-13-00749],[@B15-molecules-13-00749],[@B16-molecules-13-00749],[@B17-molecules-13-00749],[@B18-molecules-13-00749]\]. This bioassay has a good correlation with cytotoxic activity in some human solid tumours and other biological activities \[[@B19-molecules-13-00749],[@B20-molecules-13-00749]\]. In [Table 1](#molecules-13-00749-t001){ref-type="table"} we report the biological activity in the brine shrimp assay of the samples, expressed as LD~50~ (in ppm). All samples showed good activity in the brine shrimp test, in particular compound **10**, which showed a most interesting value of 1.38 ppm (LD~50~) These results suggest that these compounds could have a potential specific biological activity (anti-inflammatory or anti-viral activities for example) and further analysis are underway to prove this hypothesis.
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###### 

Biological activities of samples **1-11.**

  Cmp.                               R                                    \(a\) % inhibition ABTS +   \(b\) T.E A.C (µM)   \(c\) LD~50~ (ppm) \[95% confidence intervals\]
  ---------------------------------- ------------------------------------ --------------------------- -------------------- -------------------------------------------------
  ![](molecules-13-00749-i001.jpg)                                                                                         
  **1**                              4-methoxyphenyl                      3.4                         0.8                  4.94 \[11.04/1.73\]
  **2**                              3,4-dimethoxybenzyl                  3.06                        0.7                  9.45 \[16.25/5.43\]
  **3**                              4-morphinylphenyl                    78.19                       20.3                 9.66 \[17.51/5.27\]
  **4**                              4-methoxybenzyl                      41.8                        10.8                 5.9941 \[10.7/3.16\]
  **5**                              4-methoxyphenethyl-                  0.67                        0.17                 3.4918 \[5.77/2.05\]
  ![](molecules-13-00749-i002.jpg)                                                                                         
  **6^(d)^**                         4-methoxyphenyl                      n.a.                        n.a.                 14.34 \[54.34/4.8\]
  **7**                              3,4-dimethoxybenzyl                  7.63                        1.98                 11.97 \[28.93/5.22\]
  **8**                              4-morpholinyphenyl                   71.4                        18.6                 n.a.
  **9**                              3,5-dimethoxybenzyl                  33.93                       8.8                  25.13 \[123.08/9.36\]
  **10**                             4-fluoro- *N,N*-diethylbenzylamine   4.17                        1.08                 1.38 \[2.19/0.75\]
  **11**                             4-methoxyphenethyl-                  n.a.                        n.a.                 14.45 \[66.38/4.35\]

\(a\) Percentage of the absorbance of the uninhibited radical cation solution obtained by using ABTS method. (b) Antioxidant activity of samples expressed as T.E.A.C (µM). (c) Biological activity in brine shrimps assay of samples. In square parenthesis are shown the values of 95% confidence intervals; n.a. no activity, (d) n:1. R = amines listed in table; n = 0, 1, 2

We have also performed an extended computational and Quantitative-Structure Activity Relationship (QSAR) investigation on these molecules to define the molecular features required for high antioxidant activity. For all the molecules listed in [Table 1](#molecules-13-00749-t001){ref-type="table"}, we have calculated more than 500 molecular descriptors, covering topological, structural, and electronic properties. None of the explored parameters showed a correlation when considered singularly with the AOA. Therefore we performed a QSAR investigation via genetic functions (GF).

One of the main advantages of GF analysis is the production of multiple models. In all the models generated, crucial importance is given to electronic descriptors. We generated a total of 100 QSAR equations that consist of one to four descriptors among the QSAR random models. Among the models, the one with the strongest predictive power of the antioxidant activity (AOA) was the following:

The model described by eq.1 was obtained with the training sets **4** to **11**. The molecular descriptors of eq. 1 are described in the Computational Analysis section. Applying the "test set method" strategy we generated models using only eight out of 11 molecules. All the models obtained as outcome of the different choice of the training set, have been tested against the three molecules left out. The data shown in the last two columns of [Table 2](#molecules-13-00749-t002){ref-type="table"} have been obtained with the model generated with basis set of molecules from **4** to **11**.
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###### 

Data obtained with the model generated with basis set of molecules from **1** to **11**.

  Molecule   Experimental AOA   Dipole z^a^   Inversion energy^b^   Predicted AOA   Residual AOA
  ---------- ------------------ ------------- --------------------- --------------- --------------
  **6**      0.000              1.98          1.49                  3.74            3.74
  **11**     0.000              2.057         1.54                  5.30            5.30
  **5**      0.670              2.22          1.34                  -3.51           -4.18
  **2**      3.060              0.72          1.21                  1.48            -1.58
  **1**      3.400              -0.365        1.11                  5.20            1.80
  **10**     4.170              -0.816        1.14                  8.97            4.80
  **7**      7.630              0.522         1.48                  12.56           4.93
  **9**      33.930             -1.75         1.47                  26.52           -7.41
  **4**      41.800             1.84          1.58                  8.36            -33.44
  **8**      71.400             1.57          2.65                  71.26           -0.14
  **3**      78.200             0.265         2.63                  78.08           -0.12

^a^ values expressed in D.

^b^ values expressed in kcal/mol.

In [Figure 3](#molecules-13-00749-f003){ref-type="fig"} the comparison between calculated and experimental values is shown. The magnitudes of dipole moments and inversion energy provide an essential contribution to the antioxidant activity. Specifically, the dipole moment inversely correlates with the AOA, whereas the inversion energy directly correlates with it. The deviation of molecule **4** seems to be due to the high dipole moment together with low inversion energy. In fact, inversion energy, and consequently the molecular rigidity, has a prominent role to determine high antioxidant activities.

![Comparison of experimental and calculated values of antioxidant activity (AOA) using the model from eq. 1.](molecules-13-00749-g003){#molecules-13-00749-f003}

Cell viability was assessed by a MTT-formazan salt conversion assay, and as reported in [Table 3](#molecules-13-00749-t003){ref-type="table"}, these compounds are not cytotoxic on cellular lines used. Compounds **3** and **8**, having a morpholine ring as substituent R\" presented both antioxidant and antiproliferative activities, suggesting a possible structure-activity relationship.

molecules-13-00749-t003_Table 3

###### 

Antiproliferative activity of samples **1-11**.

  ---------------------------------------------------- ------------------------------- --------------- ---------------
  *In Vitro* Antiproliferative Activity of Compounds                                                   
                                                       IC~50~ (5% confidence limits)                   
  cmp                                                  J774.A1                         HEK-293         WEHI-164
  **3**                                                8.4 (6.7-0.11)                  3.4 (2.2-4.4)   5.4 (4.6-6.4)
  **4**                                                9.7 (1.7-14)                    \>10            \>10
  **8**                                                0.14 (0.12-0.17)                5.7 (2.3-14)    14 (13-16)
  ---------------------------------------------------- ------------------------------- --------------- ---------------

The IC~50~, express as mmoli/L, value is the concentration of compound that affords a 50% reduction in cell growth (after a 24h incubation). J774.A1 = murine monocyte/macrophage cell lines. HEK-293 = human epithelial kidney cell lines. WEHI-164 = murine fibrosarcoma cell lines.

Conclusions
===========

Results show that these diphenylpropionamide derivatives, obtained by simple and rapid chemical synthesis, had interesting biological activities and that none of the compounds are toxic. Moreover a QSAR analysis carried out using genetic functions approximation allowed us to build a chemical model (eq. 1) where electronics descriptors were of supreme importance. The statistics of the model was remarkably good, with the exception of molecule **4**, where the model predicted no antioxidant activity and the experimental measurements attribute to that compound a modest activity.

Experimental
============

General
-------

Analytical grade methanol, dichloromethane, diethyl ether and ethanol were obtained from Carlo Erba (Italy). Methanol and dichloromethane (HPLC grade) from Merck (Darmstadt, Germany) were used. 2,2\'-Azino-bis-(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) as its crystalline diammonium salt was purchased from Fluka. 6-Hydroxy-2,5,7,8-tetramethyl chroman-2-carboxylic acid (Trolox^®^) was purchased from Aldrich and potassium persulfate (K~2~S~2~O~8~) was purchased from Sigma Chemical Co. (Italy). Spectrophotometric measurements were recorded at controlled room temperature (25 °C) with a Varian DMS 90 UV-VIS spectrophotometer. Flash column chromatography was carried out using silica gel 60 (0.040-0.063 mm, Merck). Melting points were determined on a Gallenkamp hot stage apparatus and are uncorrected. ^1^H-NMR spectra were recorded on a Bruker ARX 300 MHz spectrometer. CAS Registry numbers: *N*-(4-methoxyphenyl)-2,2-diphenylpropionamide (**1**): 353466 46-3; *N*-\[(4-methoxyphenyl)methyl\]-3,3-diphenylpropionamide (**6**): 331864-56-3); *N*-\[(3,4 dimethoxyphenyl)methyl\]-3,3-diphenylpropionamide (**7**): 895679-31-9; *N*-\[4-(4-morpholinyl)phenyl\]-3,3-diphenylpropionamide (**8**): 805273-67-0); 1-(4-fluorophenyl)-4-(1-oxo-3,3-diphenylpropyl)-piperazine (**10**): 348611-42-7; *N*-\[2-(4-methoxyphenyl)ethyl\]-3,3-diphenylpropionamide (**11**): 303137-57-7.

General procedure for the synthesis of compounds **1**-**11**
-------------------------------------------------------------

Triethylamine (4 eq) was added to a solution of PPAA (2 eq), acid (1 eq), and amine (1.2 eq) in dichloromethane (5 mL), and resulting reaction mixture was stirred overnight at room temperature. The solvent was removed under reduced pressure and the residue was purified by flash chromatography (silica gel) using *n-*hexane/AcOEt (1:1) as eluent.

*N-\[(3,4-dimethoxyphenyl) methyl\]-2,2-diphenyl propionamide* (**2**). White solid (40%); mp: 70 °C; ^1^H-NMR (CDCl~3~): δ 2.08 (s, 3H, CH~3~); 3.83 (s, 3H, OCH~3~); 3.88 (s, 3H, OCH~3~); 4.43 (d, 2H, CH~2~); 5.79 (bs, 1H, NH); 6.71 (m, 2H, HAr); 6.79 (m, 1H, HAr); 7.26-7.45 (m, 10H, HAr).

*N-\[4-(4-morpholinyl)phenyl\]-2,2-diphenyl propionamide* (**3**). White solid (55%); mp: 140 °C; ^1^H-NMR (CDCl~3~) δ 2.09 (s, 3H, CH~3~); 3.13 (m, 4H, H morpholine); 3.89 (m, 4H, H morpholine), 6.89 (m, 2H, HAr), 7.10 (bs, 1H, NH), 7.30-7.40 (m, 12H, HAr).

*N-\[(4-methoxyphenyl) methyl\]-2,2-diphenyl propionamide* (**4**). White solid (65%); mp: 85 °C; ^1^H-NMR (CDCl~3~) δ 2.08 (s, 3H, CH~3~); 3.81 (s, 3H, OCH~3~); 4.42 (d, 2H, CH~2~), 5.75 (bs, 1H, NH); 6.84 (m, 2H, HAr); 7.09 (m, 2H, HAr); 7.25-7.34 (m, 10H, HAr).

*N-\[(4-methoxyphenyl)ethyl\]-2,2-diphenyl propionamide* (**5**). White solid (60%); mp: 84 °C; ^1^H-NMR (CDCl~3~) δ 2.05 (s, 3H, CH~3~); 2.70 (t, 2H, CH~2~); 3.53 (dd, 2H, CH~2~), 3.81 (s, 3H, OCH~3~), 5.46 (bs, 1H, NH); 6.78 (m, 2H, HAr); 6.93 (m, 2H, HAr), .7.15-7.18 (m, 4H, HAr); 7.28-7.32 (m, 6H, HAr).

Antioxidant activity assay by the ABTS method
---------------------------------------------

The antioxidant activity of compounds is determined by the ABTS^.^+ radical cation decolorization assay involving preformed ABTS^.^+ radical cation, according to ABTS method as previously described \[[@B21-molecules-13-00749],[@B22-molecules-13-00749]\]. A solution of ABTS 7 mM is obtained and next ABTS^.^+ radical cation is obtained by reacting ABTS with potassium persulfate; this mixture is stored in the dark at room temperature for 12-16 hr before use. Before the assay, the mixture is diluted in ethanol at a ratio 1:100 to give an absorbance at λ=734 nm of 0.70 ± 0.02. Trolox^®^ (1 mg/mL) was used as standard and aliquots of this compound (0.5 µL, 1 µL, 2 µL, 3 µL, 5 µL and 10 µL) are added to ethanolic ABTS^.^+ (1 mL) to give a standard curve to which all data are referred. All compounds are dissolved in dichloromethane at a concentration of 20 mg/mL and 5 µL are added to ethanolic ABTS^.^+ to measure absorbance after 1 min. Antioxidant activity measurements were carried out in triplicate and expressed as percentage of the absorbance of the uninhibited radical solution according to the equation: where Abs~0~ is the absorbance of uninhibited radical solution and Abs~c~ is the absorbance measured 1 min after addition of compound to assay. The antioxidant activity of samples is expressed as T.E.A.C. (Trolox^®^ Equivalent Antioxidant Capacity - µM) \[[@B23-molecules-13-00749]\].

Measurement of reactive oxygen species (ROS)
--------------------------------------------

The formation of ROS was evaluated by means of the 2\',7\'-dichlorofluorescein (DCF) probe according to the method described by Hempel *et al*. \[[@B24-molecules-13-00749]\] and Crow \[[@B25-molecules-13-00749]\] . Briefly, murine macrophage cell line, J774.A1, was seeded at a density of 5 × 10^3^ cells/well into 96-well plates and allowed to grow for 48 h. After cell adhesion, compounds **3**, **4** and **8** (0.01, 0.1 and 1 µM) were added to the culture medium 6 h before the fluorescence assay. 2\',7\'-Dichlorofluorescein-diacetate (H~2~DCF-DA, Sigma) was added directly to the growth medium at a final concentration of 5 µM and the cells incubated for 1 h at 37 °C. H~2~DCF-DA is a non-fluorescent permeant molecule which diffuses passively into cells; the acetates are then cleaved by intracellular esterases to form H~2~DCF which is thereby trapped within the cell. In the presence of intracellular ROS, H~2~DCF is rapidly oxidized to the highly fluorescent DCF. Then, cells were washed twice with phosphate-buffered saline (PBS), placed in fresh medium and treated with H~2~O~2~ 3 mM for 30 min. After treatment, cells were washed twice with PBS and the plates placed in a fluorescent microplate reader (LS 55 Luminescence Spectrometer; Perkin Elmer, Beaconsfield, Bucks, UK). Fluorescence was monitored using an excitation wavelength of 490 nm and an emission wavelength of 520 nm. Results were expressed as Relative Fluorescence Units (RFU).

Analysis of nitrite
-------------------

J774.A1 cells were plated to a seeding density of 1.5 × 10^6^ in P60 well plates. After cell adhesion, compounds **3**, **4** and **8** (0.01, 0.1 and 1 µM) were added to the culture medium 1 h before and always simultaneously to LPS (6 × 10^3^ u/ml/24 h). Nitrite accumulation, an indicator of NO release, was measured in the culture medium by Griess reaction 24 h after LPS challenge. Briefly, cell culture medium (100 µL) was mixed with Griess reagent \[100 µL, equal volumes of 1% (w/v) sulfanilamide in 5% (v/v) phosphoric acid with 0.1% (w/v) naphthylethylenediamine-HCl\], incubated at room temperature for 10 min, and then the absorbance at 550 nm was measured in a Titertek microplate reader (DASIT). Fresh culture medium was used as blank in all the experiments. The amount of nitrite in the samples was calculated from a sodium nitrite standard curve freshly prepared in culture medium. Results are expressed as µmol NO~2~.

Antiproliferative Activity Assay
--------------------------------

Compounds were dissolved in DMSO to obtain 1M concentration. J774.A1 (murine monocyte/macrophage), WEHI-164 (murine fibrosarcoma), and HEK-293 (human epithelial kidney) cells were grown as reported previously \[[@B26-molecules-13-00749]\]. J774.Al, WEHI-164, and HEK-293 (3.4 × 10^4^ cells) were plated on 96-well microtiter plates and allowed to adhere at 37°C in 5% CO~2~ and 95% air for 2 h. Thereafter the medium was replaced with 99 µL of fresh medium, and a 1 µL aliquot of 1:100 serial dilution of each test compound (tested dilutions were 10 µM 100 µM, 1 mM, 10 mM) was added and the cells were incubated for 24 h. In vehicle experiments, serial dilutions of DMSO were added. The cell viability was assessed through an MTT conversion assay \[[@B27-molecules-13-00749],[@B28-molecules-13-00749]\]. The optical density (OD) of each well was measured with a microplate spectrophotometer (Titertek Multiskan MCC/340) equipped with a 620 nm filter. The viability of each cell line in response to treatment with tested compounds was calculated as % viability cells = \[(OD DMSO-OD treatment) / OD DMSO\] × 100.

Brine Shrimp Test
-----------------

The brine shrimp (*Artemia salina*) assay was performed in triplicate with appropriate amounts of samples dissolved in DMSO (1% final volume) to reach final concentrations of 1, 10 and 100 ppm, using 10 freshly hatched larvae suspended in artificial sea water (5 mL) \[[@B29-molecules-13-00749]\]. Briefly, for each dose tested, surviving shrimps were counted after 24 h, and the data analyzed by the Finney program \[[@B30-molecules-13-00749]\], which affords LD~50~ values with 95% confidence intervals.

Computational analysis
----------------------

To construct a QSAR model the following steps should be followed: (1) assemble a sufficiently large and diverse set of compounds along with their biological activities; (2) select a set of descriptors which is likely to be related to the biological activity of interest; (3) formulate a mathematical equation that reflects the relationship between the biological activity and the chosen descriptors, and finally (4) validate the QSAR model.

For every molecule listed in [Table 1](#molecules-13-00749-t001){ref-type="table"} over 500 molecular descriptors have been calculated and the formulation of the mathematical model was accomplished by means of genetic function analysis (GFA) provided by the program MS Modeling from Accelrys \[[@B31-molecules-13-00749]\]. The GFA approach has a number of important advantages over other techniques: it builds multiple models rather than a single model; it automatically selects which elements are to be used in its basis functions and establishes the appropriate number of basis functions to be used by testing full-size models rather than incrementally building them, and it includes the LOF (lack-of-fit) error measure developed by Friedman that resists over fitting and allows user control over the smoothness of fit. Genetic algorithms are particularly good at searching problem spaces with a large number of dimensions (biological-chemical-physical parameters), as they conduct a very efficient sampling of the possibilities space.

To estimate the predictive power of this QSAR model we employed a strategy called "test set method", which consists of partitioning the initial data into two sets. The first set is used to build a QSAR model and the second one to validate this model. Then the initial data set is randomly divided into two new subsets and the procedure is repeated.

All the molecules were optimized using PM3-NDDO method until the root-mean-square gradient of the force was lower than 0.4 kcal mol^-1^Å^-1^. On the optimized structures, a DFT calculation of the electronic parameters was performed using the Perdew-Wang generalized-gradient approximation \[[@B32-molecules-13-00749]\]. With this method the total dipole, the HOMO energy and the magnitude of the dipole components, i.e. the first 3 terms of eq.1, have been calculated. The breakdown of energy components, including valence, cross terms and 4^th^ term of eq.1, the inversion energy (i.e. the inversion component of the valence energy of the system), were calculated using Forcite and the Dreiding forcefield \[[@B31-molecules-13-00749]\] and expressed in kcal mol^-1^. In order to evaluate (4) the model we have performed the calculation of the typical set of statistical measurements as reported in [Table 4](#molecules-13-00749-t004){ref-type="table"}.
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###### 

Calculation of the typical set of statistical measurements.

  ----------------------------------------------- --------------
  Friedman LOF                                    164.56185200
  R-squared                                       0.856
  Significant Regression                          Yes
  Significance-of-regression F-value              101.47
  Critical SOR F-value (95%)                      6.659
  Min expt. error for non-significant LOF (95%)   4.262
  ----------------------------------------------- --------------

The use of the Friedman lack-of-fit (LOF) measure has several advantages over the regular least square error measure. According to Friedman \[[@B33-molecules-13-00749]\], LOF is measured as: $$LOF = \frac{SSE}{\left( {1 - \frac{c + dp}{M}} \right)^{2}}$$ where SSE is the sum of squares of errors, c is the number of basis functions, other than the constant term, d is a user-defined smoothing parameter, p is the total number of features contained in all the basis functions, and M is the number of samples in the training set. Unlike the commonly used least square measure, the LOF measure cannot always be reduced by adding more terms to the regression model. By limiting the tendency to simply add more terms, the LOF measure resists over fitting better than the SSE measure. An indication of the statistical significance of the model is given by the comparison between the significance of regression F and the critical SOR F value. The comparison is a sign of statistical correlation.

*Sample availability*: Contact the authors.
